XML 16 R5.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Gain/(Loss)
Accumulated Deficit
Total
Beginning balance, shares at Dec. 31, 2022 24,722,974        
Beginning balance, value at Dec. 31, 2022 $ 2 $ 215,110 $ (466) $ (87,903) $ 126,743
Unrealized gain on investments     265   265
Issuance of common stock upon exercise of stock options   223     223
Issuance of common stock upon exercise of stock options (in shares) 93,966        
Stock based compensation   2,384     2,384
Net loss       (16,520) (16,520)
Ending balance, shares at Mar. 31, 2023 24,816,940        
Ending balance, value at Mar. 31, 2023 $ 2 217,717 (201) (104,423) 113,095
Beginning balance, shares at Dec. 31, 2022 24,722,974        
Beginning balance, value at Dec. 31, 2022 $ 2 215,110 (466) (87,903) 126,743
Net loss         (35,545)
Ending balance, shares at Jun. 30, 2023 27,601,098        
Ending balance, value at Jun. 30, 2023 $ 3 265,594 (223) (123,448) 141,926
Beginning balance, shares at Mar. 31, 2023 24,816,940        
Beginning balance, value at Mar. 31, 2023 $ 2 217,717 (201) (104,423) 113,095
Unrealized loss on investments     (22)   (22)
Issuance of common stock in connection with ATM, net $ 1 44,282     44,283
Issuance of common stock in connection with ATM, net, shares 2,662,721        
Issuance of common stock upon exercise of stock options   333     333
Issuance of common stock upon exercise of stock options (in shares) 106,756        
Issuance of common stock under ESPP   228     228
Issuance of common stock under ESPP, shares 13,866        
Vesting of restricted stock units, shares 815        
Stock based compensation   3,034     3,034
Net loss       (19,025) (19,025)
Ending balance, shares at Jun. 30, 2023 27,601,098        
Ending balance, value at Jun. 30, 2023 $ 3 265,594 (223) (123,448) 141,926
Beginning balance, shares at Dec. 31, 2023 27,762,703        
Beginning balance, value at Dec. 31, 2023 $ 3 272,640 237 (163,424) 109,456
Unrealized loss on investments     (270)   (270)
Issuance of common stock upon exercise of stock options   704     704
Issuance of common stock upon exercise of stock options (in shares) 133,282        
Vesting of restricted stock units, shares 2,776        
Stock based compensation   4,200     4,200
Net loss       (23,186) (23,186)
Ending balance, shares at Mar. 31, 2024 27,898,761        
Ending balance, value at Mar. 31, 2024 $ 3 277,544 (33) (186,610) 90,904
Beginning balance, shares at Dec. 31, 2023 27,762,703        
Beginning balance, value at Dec. 31, 2023 $ 3 272,640 237 (163,424) $ 109,456
Issuance of common stock upon exercise of stock options (in shares)         252,521
Net loss         $ (47,961)
Ending balance, shares at Jun. 30, 2024 28,854,750        
Ending balance, value at Jun. 30, 2024 $ 3 305,863 (83) (211,385) 94,398
Beginning balance, shares at Mar. 31, 2024 27,898,761        
Beginning balance, value at Mar. 31, 2024 $ 3 277,544 (33) (186,610) 90,904
Unrealized loss on investments     (50)   (50)
Issuance of common stock in connection with ATM, net   23,635     23,635
Issuance of common stock in connection with ATM, net, shares 800,000        
Issuance of common stock upon exercise of stock options   511     511
Issuance of common stock upon exercise of stock options (in shares) 119,239        
Issuance of common stock under ESPP   308     308
Issuance of common stock under ESPP, shares 34,034        
Vesting of restricted stock units, shares 2,716        
Stock based compensation   3,865     3,865
Net loss       (24,775) (24,775)
Ending balance, shares at Jun. 30, 2024 28,854,750        
Ending balance, value at Jun. 30, 2024 $ 3 $ 305,863 $ (83) $ (211,385) $ 94,398